Is the Sirolimus encapsulated balloon a reliable tool for treating the in-stent restenosis?-insights from the SABRE trial
Journal of Thoracic Disease
4
Aprile
Apr
2018
8 years ago
Comment on
The SABRE Trial (Sirolimus Angioplasty Balloon for Coronary In-Stent Restenosis): Angiographic Results and 1-Year Clinical Outcomes. [JACC Cardiovasc Interv. 2017]
Reference
Andreini D, Trabattoni D. Is the Sirolimus encapsulated balloon a reliable tool for treating the in-stent restenosis?-insights from the SABRE trial. J Thorac Dis 2018 Feb;10(2):634-637